Skip to content
Pharma Observatory a Scientist.com platform

Clinical trial

Adaption of the EORTC Quality of Life Breast Cancer Module for Male Breast Cancer - Phase I

NCT07455110 is registered in ClinicalTrials.gov with Helios University Hospital Wuppertal as lead sponsor.

NCT NCT07455110
Email me this page as a PDF

Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.

Get the NCT07455110 report as a PDF

The PDF carries up to 50 rows of each section, where the page shows the first few, with the sources listed. Enter a work email and confirm it from the message we send, and the report follows by email.

Registry record

As filed in ClinicalTrials.gov.

Title
Adaption of the EORTC Quality of Life Breast Cancer Module for Male Breast Cancer - Phase I
Lead sponsor
Helios University Hospital Wuppertal
Phase
Observational
Overall status
Completed
Start date
November 1, 2019
Completion date
March 31, 2023
Enrollment
65 (actual)
Sites
1

Conditions

As the registry lists them; a condition with its own page is linked.

breast cancer, male breast cancer, quality of life